We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK’s MHRA Calls for Quicker Clinical Trial Safety Reporting
UK’s MHRA Calls for Quicker Clinical Trial Safety Reporting
March 18, 2008
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) says it will take immediate steps to strengthen laws requiring drug companies to report safety signals in clinical trials.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor